RecruitingPhase not listed

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
No age limits stated
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study builds a list of people who may join current or future studies of childhood asthma in urban areas. It does not test a treatment. Adults and children who live in a qualifying city area or its surrounding communities may join.

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • If you are 18 or older, you must be willing and able to give consent to join.
  • If you are under 18, you must come with a legal guardian who is willing and able to give consent.
  • Your main home must be in a Metropolitan Statistical Area, a city area and nearby communities defined by the federal government.

Who can't join

  • You or your guardian do not speak English or Spanish.
  • You do not have regular access to a personal or public phone for scheduling and safety checks.
  • The study doctor believes a health problem or test result could make joining unsafe, make it hard to follow study rules, or affect the study's data.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Participant is either: 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA) Exclusion Criteria: 1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy. Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.

Study sites (7)

CO

DC

IL

MA

  • Boston Children's Hospital: Department of Immunology · Boston, MA 02215 · Study contact · 617-919-1301Wanda Phipatanakul · Principal investigatorMore trials in Boston

NY

OH